India Generics Makers Could Get Faster Approval Under EC Proposal
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers stand to receive faster approvals in the European Union for their generics if the European Commission follows through on a proposal to change standards for pricing and reimbursements.